| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.4M | +187.5% |
| Cost of Revenue | $9.1M | +60.3% |
| Gross Profit | $3.5M | +102.2% |
| R&D Expense | $709K | +16.2% |
| SG&A Expense | $1.2M | -15.0% |
| Operating Income | $1.7M | +904.7% |
| Pre-tax Income | $1.2M | +418.1% |
| Net Income | $945K | +390.9% |
| EPS (Basic) | $0.04 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $167K | -51.3% |
| Accounts Receivable | $2.9M | +6870.7% |
| Inventory | $2.9M | +76.0% |
| Current Assets | $7.0M | +211.4% |
| Total Assets | $29.8M | +13.4% |
| Current Liabilities | $13.8M | +14.6% |
| Long-term Debt | $1.2M | -12.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.5M | +1189.5% |
| Capital Expenditures | $685K | — |
| Investing Cash Flow | -$685K | — |
| Financing Cash Flow | -$1.0M | -199.5% |
| Free Cash Flow | $861K | — |
| +300.0% |
| EPS (Diluted) | $0.04 | +300.0% |
| Total Liabilities |
| $16.0M |
| +18.6% |
| Stockholders' Equity | $10.3M | +8.1% |